You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
特寶生物(688278.SH):全資子公司擬收購 Skyline Therapeutics Limited部分資產
格隆匯 02-21 19:23

格隆匯2月21日丨特寶生物(688278.SH)公佈,公司的全資子公司廈門伯賽基因轉錄技術有限公司(以下簡稱“伯賽基因”或“買方”)擬以自有資金收購 Skyline Therapeutics Limited(以下簡稱“九天開曼”或“標的公司”)部分資產,本次收購範圍包括九天開曼及其下屬公司的資產(不包含其下屬公司 SkylineTherapeutics (US) Inc.及其已取得的資產或權利)。本次交易完成後,標的公司將成為伯賽基因的全資子公司,納入公司合併報表範圍。

本次交易對價包含合併對價和附加合併對價,其中合併對價為1500萬美元;附加合併對價為在協議約定條件滿足時,由最高不超過4300萬美元的開發和銷售里程碑款,再許可提成和按年淨銷售額個位數百分比計算的銷售提成構成。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account